590 related articles for article (PubMed ID: 26775592)
61. An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.
Ashworth AB; Senan S; Palma DA; Riquet M; Ahn YC; Ricardi U; Congedo MT; Gomez DR; Wright GM; Melloni G; Milano MT; Sole CV; De Pas TM; Carter DL; Warner AJ; Rodrigues GB
Clin Lung Cancer; 2014 Sep; 15(5):346-55. PubMed ID: 24894943
[TBL] [Abstract][Full Text] [Related]
62. Stereotactic body radiotherapy in early stage non-small cell lung cancer: first experience from an Indian Centre.
Kundu S; Mathew A; Munshi A; Prabhash K; Pramesh CS; Agarwal JP
Indian J Cancer; 2013; 50(3):227-32. PubMed ID: 24061463
[TBL] [Abstract][Full Text] [Related]
63. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery.
Palma D; Visser O; Lagerwaard FJ; Belderbos J; Slotman B; Senan S
Radiother Oncol; 2011 Nov; 101(2):240-4. PubMed ID: 21775007
[TBL] [Abstract][Full Text] [Related]
64. Oligometastatic breast cancer: where are we now and where are we headed?-a narrative review.
Kent CL; McDuff SGR; Salama JK
Ann Palliat Med; 2021 May; 10(5):5954-5968. PubMed ID: 32921069
[TBL] [Abstract][Full Text] [Related]
65. Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates.
Jeppesen SS; Schytte T; Jensen HR; Brink C; Hansen O
Acta Oncol; 2013 Oct; 52(7):1552-8. PubMed ID: 23902274
[TBL] [Abstract][Full Text] [Related]
66. [Outcome of three-dimensional conformal radiotherapy for early stage non-small cell lung cancer patients who met or not inclusion criteria for stereotactic-body radiation therapy].
Kołodziejczyk M; Kępka L; Tyc-Szczepaniak D; Wierzchowski M
Pneumonol Alergol Pol; 2011; 79(5):326-36. PubMed ID: 21861256
[TBL] [Abstract][Full Text] [Related]
67. Stereotactic body radiotherapy in operable patients with stage I NSCLC: where is the evidence?
Guckenberger M
Expert Rev Anticancer Ther; 2015 May; 15(5):525-30. PubMed ID: 25761997
[TBL] [Abstract][Full Text] [Related]
68. Radical treatment of oligometastatic non-small cell lung cancer: Ready for prime time?
Brighenti M; Petrelli F; Barni S; Conti B; Sarti E; Ratti M; Panni S; Passalacqua R; Bersanelli M
Eur J Cancer; 2017 Jul; 79():149-151. PubMed ID: 28494405
[TBL] [Abstract][Full Text] [Related]
69. Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients.
Chen F; Matsuo Y; Yoshizawa A; Sato T; Sakai H; Bando T; Okubo K; Shibuya K; Date H
J Thorac Oncol; 2010 Dec; 5(12):1999-2002. PubMed ID: 21102261
[TBL] [Abstract][Full Text] [Related]
70. What do radiation oncologists require for future advancements in lung SBRT?
Ricardi U; Badellino S; Filippi AR
Phys Med; 2017 Dec; 44():150-156. PubMed ID: 27914779
[TBL] [Abstract][Full Text] [Related]
71. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: A propensity score matching analysis.
Matsuo Y; Chen F; Hamaji M; Kawaguchi A; Ueki N; Nagata Y; Sonobe M; Morita S; Date H; Hiraoka M
Eur J Cancer; 2014 Nov; 50(17):2932-8. PubMed ID: 25281527
[TBL] [Abstract][Full Text] [Related]
72. [Local ablative radiotherapy of oligometastatic colorectal cancer].
Petersen C; Gauer T
Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
[TBL] [Abstract][Full Text] [Related]
73. Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review.
Chicas-Sett R; Morales-Orue I; Castilla-Martinez J; Zafra-Martin J; Kannemann A; Blanco J; Lloret M; Lara PC
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052488
[No Abstract] [Full Text] [Related]
74. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
75. Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer.
Campo M; Al-Halabi H; Khandekar M; Shaw AT; Sequist LV; Willers H
Oncologist; 2016 Aug; 21(8):964-73. PubMed ID: 27354669
[TBL] [Abstract][Full Text] [Related]
76. Ablative or palliative stereotactic body radiotherapy with helical tomotherapy for primary or metastatic lung tumor.
Marcenaro M; Vagge S; Belgioia L; Agnese D; Lamanna G; Mantero E; Gusinu M; Garelli S; Cavagnetto F; Agostinelli S; Corvò R
Anticancer Res; 2013 Feb; 33(2):655-60. PubMed ID: 23393363
[TBL] [Abstract][Full Text] [Related]
77. Safety and efficacy of stereotactic body radiotherapy for stage 1 non-small-cell lung cancer in routine clinical practice: a patterns-of-care and outcome analysis.
Guckenberger M; Allgäuer M; Appold S; Dieckmann K; Ernst I; Ganswindt U; Holy R; Nestle U; Nevinny-Stickel M; Semrau S; Sterzing F; Wittig A; Andratschke N
J Thorac Oncol; 2013 Aug; 8(8):1050-8. PubMed ID: 23817193
[TBL] [Abstract][Full Text] [Related]
78. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
79. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries.
Baumann P; Nyman J; Lax I; Friesland S; Hoyer M; Rehn Ericsson S; Johansson KA; Ekberg L; Morhed E; Paludan M; Wittgren L; Blomgren H; Lewensohn R
Acta Oncol; 2006; 45(7):787-95. PubMed ID: 16982541
[TBL] [Abstract][Full Text] [Related]
80. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
Britschgi C; Riesterer O; Burger IA; Guckenberger M; Curioni-Fontecedro A
Radiat Oncol; 2018 May; 13(1):102. PubMed ID: 29855323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]